Learn more

MOGAM BIOTECHNOLOGY INST

Overview
  • Total Patents
    84
  • GoodIP Patent Rank
    166,666
About

MOGAM BIOTECHNOLOGY INST has a total of 84 patent applications. Its first patent ever was published in 1992. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are NANJING BIOHENG BIOTECH CO LTD, POSEIDA THERAPEUTICS INC and CRUCELL HOLLAND BV.

Patent filings per year

Chart showing MOGAM BIOTECHNOLOGY INSTs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Moon Hong-Mo 15
#2 Park Du Hong 10
#3 Jung Gyeong Hwan 7
#4 Oh Jong Eun 7
#5 Kim Jang Seong 6
#6 Jung Su Il 6
#7 Lee Geon Hyeong 6
#8 Lee Sumin 5
#9 Kwak Heechun 5
#10 Hwang Yu-Kyung 5

Latest patents

Publication Filing date Title
EP2794859A1 Method for producing natural killer cells, natural killer cells produced thereby, and composition for treating cancers and infectious diseases containing the same
WO2007148840A1 Methods for enhancing a secretion efficiency of recombinant foreign protein in yeast expression system
WO2006022459A1 Primer and probe for detection of sars coronavirus, kit comprising the primer and/or the probe, and detection method thereof
KR20050078743A Pharmaceutical composition comprising hydroxylphenyl derivatives of rosmarinic acid for anticancer
KR20050077399A Transformed saccharomyces cerevisiae and production method of lk8 protein using the same
KR20040087543A Crystalizing method of kringle proteins
KR20040075270A Anticancer agent comprising LK8 protein as an active ingredient
KR20040069840A Method for mass production of angiogenesis inhibitor LK8 protein
KR20040041418A Angiogenesis inhibitor containing sulfonamide derivatives
KR20040027204A Serum-free media for cell culturing
KR20030082006A Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition
KR20030079194A Large-scale purification method of shLkn-1 protein with high purity using recombinant yeast
KR20030065042A Mass production method of shLkn-1 protein using recombinant yeast
KR20030062773A RNA as template for efficient de novo RNA synthesis by HCV NS5B polymerase
KR20020007891A Screening method of antivirial agent by protein-priming activity of hepatitis B virus DNA Pol
KR20020006643A Rosmarinic acid derivatives as an immunosuppressant and an inhibitor of sh2
KR20010103511A Method for preparation of recombinant Guamerin and pharmaceutical compositions containing the recombinant Guamerin for wound healing
KR20020047168A A novel angiogenesis inhibitor
KR20020047167A Novel detoxified mutants of Escherichia coli heat-labile enterotoxin
KR20000072988A Use of rosmarinic acid and derivatives thereof as an immunosuppressant and an inhibitor of SH2-mediated process